1. Pro-fibrotic activity of lysophosphatidic acid in adipose tissue: In vivo and in vitro evidence
- Author
-
Jean-Loup Bascands, Pauline Decaunes, Philippe Valet, Chloé Rancoule, Jean Sébastien Saulnier-Blache, Sandra Grès, Nathalie Viguerie, Manon Viaud, Anne Bouloumié, Dominique Langin, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Biochimie, CHU Toulouse [Toulouse]-Institut Fédératif de Biologie (IFB) - Hôpital Purpan, Hôpital Purpan [Toulouse], CHU Toulouse [Toulouse]-CHU Toulouse [Toulouse]-Hôpital Purpan [Toulouse], CHU Toulouse [Toulouse], Simon, Marie Francoise, Laboratoire de Biochimie [CHU Toulouse], Institut Fédératif de Biologie (IFB), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Pôle Biologie [CHU Toulouse], and Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)
- Subjects
Male ,Mice, Obese ,Adipose tissue ,Tissue Culture Techniques ,Mice ,chemistry.chemical_compound ,0302 clinical medicine ,Transforming Growth Factor beta ,Fibrosis ,MESH: Collagen ,Lysophosphatidic acid ,MESH: Receptors, Lysophosphatidic Acid ,MESH: Animals ,MESH: Propionates ,Receptors, Lysophosphatidic Acid ,Receptor ,MESH: Mice, Obese ,0303 health sciences ,MESH: Indazoles ,Adipose Tissue ,030220 oncology & carcinogenesis ,MESH: Fibrosis ,Female ,lipids (amino acids, peptides, and proteins) ,Collagen ,Autotaxin ,MESH: Adipose Tissue ,medicine.medical_specialty ,Indazoles ,Enzyme Activators ,Biology ,MESH: Actins ,MESH: Hypoxia-Inducible Factor 1, alpha Subunit ,MESH: Lysophospholipids ,03 medical and health sciences ,In vivo ,Internal medicine ,medicine ,Animals ,Humans ,MESH: Enzyme Activators ,MESH: Tissue Culture Techniques ,MESH: Mice ,Molecular Biology ,MESH: Transforming Growth Factor beta ,030304 developmental biology ,MESH: Humans ,Isoxazoles ,Cell Biology ,Hypoxia-Inducible Factor 1, alpha Subunit ,medicine.disease ,Actins ,MESH: Male ,In vitro ,CTGF ,Endocrinology ,MESH: Isoxazoles ,chemistry ,Lysophospholipids ,Propionates ,MESH: Female - Abstract
International audience; Lysophosphatidic acid (LPA) is a pro-fibrotic mediator acting via specific receptors (LPARs) and is synthesized by autotaxin, that increases with obesity. We tested whether LPA could play a role in adipose tissue (AT)-fibrosis associated with obesity. Fibrosis [type I, III, and IV collagens (COL), fibronectin (FN), TGFβ, CTGF and αSMA] and inflammation (MCP1 and F4/80) markers were quantified: (i) in vivo in inguinal (IAT) and perigonadic (PGAT) AT from obese-diabetic db/db mice treated with the LPAR antagonist Ki16425 (5mg/kg/day ip for 7 weeks); and (ii) in vitro in human AT explants in primary culture for 72h in the presence of oleoyl-LPA (10μM) and/or Ki16425 (10μM) and/or the HIF-1α inhibitor YC-1 (100μM). Treatment of db/db mice with Ki16425 reduced Col I and IV mRNAs in IAT and PGAT while Col III mRNAs were only reduced in IAT. This was associated with reduction of COL protein staining in both IAT and PGAT. AT explants showed a spontaneous and time-dependent increase in ATX expression and production of LPA in the culture medium, along with increased levels of Col I and III, TGFβ and αSMA mRNAs and of COL protein staining. In vitro fibrosis was blocked by Ki16425 and was further amplified by oleoyl-LPA. LPA-dependent in vitro fibrosis was blocked by co-treatment with YC1. Our results show that endogenous and exogenous LPA exert a pro-fibrotic activity in AT in vivo and in vitro. This activity could be mediated by an LPA1R-dependent pathway and could involve HIF-1α.
- Published
- 2014